Baxa Corporation announces that it has unified its US and European operations under a single notified body, the British Standards Institution (BSI), and achieved registration to the ISO-13485:2003 standard. The company recently named BSI as its new registrar and completed its first official assessment with them. BSI assessed Baxa Corporation's management system conformity to ISO-13485:2003,
the upgrade to the ISO-13485:1996 standard to which it had been previously registered.
PR Newswire
Simplifying Global Compliance
Recommended Products
EU MDR Compliance: A Checklist for Meeting Manufacturing, Safety and Performance Requirements
The FDAnews report EU MDR Compliance can help. Our editors have combed through the regulations, picking out the most minute compliance points and building them into a checklist of 200+ requirements you can use to confirm that you are satisfying all the EU mandates for device manufacturing.
Accelerating Generic Drug Development: The FDA’s New Plan for Increasing Generic Competition
Accelerating Generic Drug Development explains the FDA’s new policy and shows how to navigate the new pathway to approval.
Editor's Picks
Lax Quality Observed at Device Facility in China
The company failed to investigate a customer complaint about a malfunctioning device.
Three Breast Cancer Drugs Pose Risks of Lung Inflammation, FDA Says
Possible symptoms include shortness of breath while resting or during low physical activity, the agency said.
FDAnews Device Daily Bulletin
BAXA CORPORATION REGISTERED TO NEW ISO STANDARD UNDER BSI
May 4, 2006
